Get the evidence you need to supercharge your program in Hidradenitis Suppurativa
Schedule a DemoPremiOM Data
250,000+
Patients with Hidradenitis Suppurativa (HS) in the OM1 Real-World Data Cloud
43,000+
HS patients prospectively followed by dermatologists, with clinical notes, linked EMR & claims for deep clinical insights
Dataset highlights:
- Hurley Stage scores
- Estimated Hurley Stage (ML generated)
- Anatomic location of disease
- Disease manifestation (i.e., cyst, nodule, abscess)
- Steroid dosing and exposure
- Use of bDMARDs
How we help
Data Licensing
Fill in your data gaps with OM1’s specialty curated HS PremiOM dataset. Achieve a better understanding of HS patient journeys, clinical endpoints, and outcomes with direct and linked data.
Research & Analytics
Put OM1’s experts to work. Designing real-world studies and understanding complex conditions like HS can be difficult – our award winning team offers comprehensive research and analytics support every step of the way.
Prospective Evidence Generation
OM1 is at the forefront of prospective research innovation. With OM1’s expansive dermatology data network and our tech-enabled study platform, the hard-to-get HS measures you need can be collected faster, cheaper, and with reduced site burden.
AI-powered Insights
OM1’s award-winning AI solutions can help you understand the complex HS patient journey from end-to-end and highlight patients of interest.
Beyond skin deep: Real-world data that captures the complexity of Hidradenitis Suppurativa
Chronic diseases like HS know no boundaries—neither should your data. Unlock comprehensive insights with real-world data that reflects the full HS patient journey.
Underdiagnosed and unseen
It’s common for patients with HS to live with the disease for 12 or more years before receiving a correct diagnosis.
OM1 is leveraging our award-winning AI and digital phenotyping platform, PhenOM, to find underdiagnosed HS patients earlier and faster to understand the true HS patient journey and improve outcomes.
See the whole picture
Immune-mediated dermatological diseases are more than just skin conditions. They’re complex, multi-system disorders.
HS patients often experience depression, anxiety, obesity, and other comorbidities. OM1’s multi-source, specialty and cross-therapeutic data – including curated mental health and cardiometabolic outcomes – enable holistic insights that captures the complexity of HS.
Outcomes that matter
What can’t be measured, can’t be evaluated – which is why disease-specific outcomes matter.
With over 80,000 observed and estimated Hurley Stage classifications available in over 23,000 patients, the PremiOM HS dataset enables critical insights into treatment effectiveness and disease progression.
Dermatology’s Largest Data Network
Powered by OM1 & AAD
As the leading provider of dermatological real-world data, OM1’s strategic partnership with the American Academy of Dermatology ensures that you have access to the highest quality data from over 5,000 specialty providers across the U.S.
Featured HS Insights
Let’s shape the future of Hidradenitis Suppurativa treatment together.
Connect with our team to learn more about OM1’s work in HS and how we can help you achieve your goals.
